Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Acme United ACU 25. avr 2025 41.55 -1.59   
 ACNB ACNB 25. avr 2025 40.98 -0.70   
 ACRES Commercial Realty ACR 25. avr 2025 18.58 +4.50   
 ACRES Commercial Realty C Pref ACR-C 25. avr 2025 24.75 +1.56   
 ACRES Commercial Realty D Pref ACR-D 25. avr 2025 20.79 +0.43   
 Acrivon Therapeutics ACRV 25. avr 2025 1.64 -17.59   
 Actelis Networks ASNS 25. avr 2025 0.73 +2.82   
 Actinium Pharmaceuticals ATNM 25. avr 2025 1.31 +3.15   
 Active Bear ETF HDGE 25. avr 2025 18.84 -0.19   
 Active U.S. Real Estate Powershares PSR 25. avr 2025 89.32 -0.23   
 Actuate Therapeutics ACTU 25. avr 2025 8.95 -1.00   
 Acuity AYI 25. avr 2025 242.84 -0.24   
 Acumen Pharmaceuticals ABOS 25. avr 2025 1.08 -1.82   
 Acuren TIC 25. avr 2025 9.73 0.00   
 Acurx Pharmaceuticals ACXP 25. avr 2025 0.40 +0.72   
 Acushnet GOLF 25. avr 2025 62.09 -1.43   
 ACV Auctions ACVA 25. avr 2025 14.80 -0.27   
 ACWI Ex-US Index MSCI Ishares ACWX 25. avr 2025 56.54 +0.18   
 ACWI Index MSCI Ishares ACWI 25. avr 2025 116.18 +0.58   
 Adagene ADR ADAG 25. avr 2025 1.42 +2.16   
 Adagio Medical ADGM 25. avr 2025 1.30 +14.04   
 Adams Diversified Equity Fund ADX 25. avr 2025 19.05 +1.11   
 Adams Natural Resources Fund PEO 25. avr 2025 20.58 +0.24   
 AdaptHealth AHCO 25. avr 2025 8.41 +4.73   
 Adaptimmune Therapeutics ADR ADAP 25. avr 2025 0.27 -0.49   
 Adaptive Biotechnologies ADPT 25. avr 2025 7.90 +0.13   
 ADC Therapeutics SA ADCT 25. avr 2025 1.33 -2.21   
 Addentax Group ATXG 25. avr 2025 0.70 +7.48   
 Addex Therapeutics ADR ADXN 25. avr 2025 8.16 +7.37   
 Addus HomeCare ADUS 25. avr 2025 100.58 +1.04   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.